# A Study to Understand the Effect of Tablet Formulation and Food on PF-06821497 in Healthy Adult Participants.

> **NCT05767905** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-06821497 Treatment A
- **DRUG:** PF-06821497 Treatment B
- **DRUG:** PF-06821497 Treatment C
- **DRUG:** PF-06821497 Treatment D
- **DRUG:** PF-06821497 Treatment E
- **DRUG:** PF-06821497 Treatment F

## Key facts

- **NCT ID:** NCT05767905
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-17
- **Primary completion:** 2023-06-20
- **Final completion:** 2023-06-20
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05767905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05767905, "A Study to Understand the Effect of Tablet Formulation and Food on PF-06821497 in Healthy Adult Participants.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05767905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*